Open AccessFluorine‐19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications
Author(s) -
Rose Laura C.,
Kadayakkara Deepak K.,
Wang Guan,
Bar-Shir Am,
Helfer Brooke M.,
O'Hanlon Charles F.,
Kraitchman Dara L.,
Rodriguez Ricardo L.,
Bulte Jeff W.M.
Publication year - 2015
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2015-0113
Subject(s) - stromal vascular fraction , cd34 , stromal cell , chemistry , adipose tissue , progenitor cell , cell therapy , mesenchymal stem cell , pathology , cancer research , stem cell , cell , medicine , biology , microbiology and biotechnology , biochemistry
The location and persistence of stromal vascular fraction (SVF) cells, used clinically for various therapeutic targets, are important for determining treatment failure and success. The GID SVF‐1 platform and a clinical protocol to harvest and label SVF cells with fluorinated ( 19 F) CS‐1000 were successfully developed to track SVF cells with magnetic resonance imaging during radiation‐induced fibrosis treatment in breast cancer patients.